Differential Response Between African Americans and Non-African Americans with Resistant Hypertension to MANP, a Novel ...
The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the past 2 decades ...
March 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...
For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...
Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAKâ„¢-1 Phase 1b/2 Clinical Trial of TN-201SOUTH ...
today announced its presentation of clinical trial results at the 2025 Annual Meeting of the American College of Cardiology. The presentation, “Differential Response Between African Americans ...
The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...
Medtronic plc’s Evolut Low-Risk trial continued to show non-inferiority of transcatheter aortic valve replacement to surgical ...
New data from the cardiac magnetic resonance (CMR) imaging sub-studies of FOREST-HCM and SEQUOIA-HCM will be presented in a moderated poster presentation. At the time of the current analysis ...
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback